BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3034992)

  • 1. Prevention of viral myocarditis with recombinant human leukocyte interferon alpha A/D in a murine model.
    Matsumori A; Crumpacker CS; Abelmann WH
    J Am Coll Cardiol; 1987 Jun; 9(6):1320-5. PubMed ID: 3034992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.
    Kishimoto C; Crumpacker CS; Abelmann WH
    Cardiovasc Res; 1988 Oct; 22(10):732-8. PubMed ID: 2855719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of viral myocarditis with ribavirin in an animal preparation.
    Matsumori A; Wang H; Abelmann WH; Crumpacker CS
    Circulation; 1985 Apr; 71(4):834-9. PubMed ID: 2982522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice.
    Matsumori A; Tomioka N; Kawai C
    Am Heart J; 1988 Jun; 115(6):1229-32. PubMed ID: 2837073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
    Yamada T; Matsumori A; Sasayama S
    Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil ameliorates the clinical and pathological course of murine myocarditis.
    Dong R; Liu P; Wee L; Butany J; Sole MJ
    J Clin Invest; 1992 Nov; 90(5):2022-30. PubMed ID: 1331179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. French maritime pine bark extract inhibits viral replication and prevents development of viral myocarditis.
    Matsumori A; Higuchi H; Shimada M
    J Card Fail; 2007 Nov; 13(9):785-91. PubMed ID: 17996829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunostimulant therapy on acute viral myocarditis in an animal model.
    Sato Y; Maruyama S; Kawai C; Matsumori A
    Am Heart J; 1992 Aug; 124(2):428-34. PubMed ID: 1322031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.
    Monrad ES; Matsumori A; Murphy JC; Fox JG; Crumpacker CS; Abelmann WH
    Circulation; 1986 May; 73(5):1058-64. PubMed ID: 3698228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy.
    Kyu B; Matsumori A; Sato Y; Okada I; Chapman NM; Tracy S
    Circulation; 1992 Aug; 86(2):522-30. PubMed ID: 1322254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of viral myocarditis in mice by interleukin-6.
    Kanda T; McManus JE; Nagai R; Imai S; Suzuki T; Yang D; McManus BM; Kobayashi I
    Circ Res; 1996 May; 78(5):848-56. PubMed ID: 8620605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.
    Kanda T; Kogure S; Nara M; Tsukui S; Utsugi T; Tomono S; Kawazu S; Nagai R; Kobayashi I
    Eur J Pharmacol; 1998 Jan; 342(2-3):297-302. PubMed ID: 9548400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis.
    Kishimoto C; Thorp KA; Abelmann WH
    Circulation; 1990 Sep; 82(3):982-9. PubMed ID: 2168299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalomyocarditis (EMC) virus myocarditis in DBA/2 mice. I. Acute stage.
    Matsumori A; Kawai C; Sawada S
    Jpn Circ J; 1981 Dec; 45(12):1403-8. PubMed ID: 6275136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus.
    Matsumori A; Kawai C; Crumpacker CS; Abelmann WH
    Jpn Circ J; 1987 Jun; 51(6):661-4. PubMed ID: 2822976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
    Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
    J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist.
    Ono K; Matsumori A; Shioi T; Furukawa Y; Sasayama S
    Circulation; 1999 Oct; 100(17):1823-9. PubMed ID: 10534471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
    Kanda T; Yokoyama T; Suzuki T; Murata K
    Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Kurokawa M; Ochiai H; Shiraki K; Sasayama S
    Cardiovasc Res; 1993 Jun; 27(6):957-61. PubMed ID: 8221785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice.
    Ito H; Ono K; Nishio R; Sasayama S; Matsumori A
    Cytokine; 2002 Feb; 17(4):197-202. PubMed ID: 11991672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.